| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.25 | 3e-05 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.24 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | selumetinib:vorinostat (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.2 | 0.0003 |